Compare NUTX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | XBIT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.5M | 73.2M |
| IPO Year | N/A | 2015 |
| Metric | NUTX | XBIT |
|---|---|---|
| Price | $172.38 | $2.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $252.50 | N/A |
| AVG Volume (30 Days) | ★ 213.5K | 63.5K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 17.98 | N/A |
| Revenue | ★ $981,195,633.00 | N/A |
| Revenue This Year | $104.36 | N/A |
| Revenue Next Year | $4.10 | N/A |
| P/E Ratio | $9.56 | ★ N/A |
| Revenue Growth | ★ 236.03 | N/A |
| 52 Week Low | $28.12 | $2.09 |
| 52 Week High | $193.00 | $6.66 |
| Indicator | NUTX | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 61.13 | 51.36 |
| Support Level | $156.15 | $2.40 |
| Resistance Level | $193.00 | $2.55 |
| Average True Range (ATR) | 15.02 | 0.13 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 76.03 | 42.42 |
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.